BCM
TEVA icon

Barometer Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Barometer Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
89,000
+11,200
+14% +$373K 0.84% 29
2026
Q1 		$2.34M Buy
+77,800
New +$2.5M 0.8% 30
2025
Q3 		– Sell
-19,700
Closed -$330K – 207
2025
Q2 		$330K Buy
19,700
+6,800
+53% +$110K 0.09% 121
2025
Q1 		$198K Buy
12,900
+2,800
+28% +$50K 0.07% 115
2024
Q4 		$223K Buy
10,100
+700
+7% +$12.7K 0.09% 98
2024
Q3 		$169K Buy
+9,400
New +$165K 0.05% 129

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Barometer Capital Management's TEVA Position: Q2 2026 in Review

Barometer Capital Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 14% in Q2 2026, buying an estimated $373K and bringing the position to 89,000 shares worth $3.02M. The position accounts for 0.84% of the portfolio, ranked #29.

Barometer Capital Management first reported a position in TEVA in Q3 2024 and has held it in 6 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Barometer Capital Management held 89,000 shares of Teva Pharmaceutical Industries Limited worth $3.02M as of Q2 2026.
  • Barometer Capital Management bought 11,200 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $373K.
  • Teva Pharmaceutical Industries Limited made up 0.84% of Barometer Capital Management's portfolio in Q2 2026, its #29 holding.
  • Barometer Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and has held it in 6 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Barometer Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.